Found: 132
Select item for more details and to access through your institution.
Driver mutations associated with signatures of platinum sensitivity in germ cell tumors.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00727-2
- By:
- Publication type:
- Article
Prostate angiosarcoma: is there any association with previous radiation therapy?
- Published in:
- BJU International, 2012, v. 110, n. 11c, p. E819, doi. 10.1111/j.1464-410X.2012.11202.x
- By:
- Publication type:
- Article
The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11b, p. E575, doi. 10.1111/j.1464-410X.2012.11286.x
- By:
- Publication type:
- Article
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
- Published in:
- BJU International, 2012, v. 109, n. 1, p. 32, doi. 10.1111/j.1464-410X.2011.10422.x
- By:
- Publication type:
- Article
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.
- Published in:
- BJU International, 2011, v. 108, n. 3, p. 378, doi. 10.1111/j.1464-410X.2010.09878.x
- By:
- Publication type:
- Article
Sustained complete response to cytotoxic therapy and the PARP inhibitor veliparib in metastatic castration-resistant prostate cancer - a case report.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00169
- By:
- Publication type:
- Article
Src: marker or actor in prostate cancer aggressiveness.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00222
- By:
- Publication type:
- Article
Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 1, p. e31, doi. 10.1016/j.clgc.2023.06.013
- By:
- Publication type:
- Article
Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 183, doi. 10.1016/j.clgc.2021.11.015
- By:
- Publication type:
- Article
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 97, doi. 10.1016/j.clgc.2021.08.001
- By:
- Publication type:
- Article
Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy--Focus on Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 7, p. 14800, doi. 10.3390/ijms140714800
- By:
- Publication type:
- Article
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Case report: Salivary duct carcinoma in a patient with a germline CDH1 pathogenic variant - expanding the spectrum of hereditary cancer predisposition syndromes.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1372382
- By:
- Publication type:
- Article
Chemotherapy and its evolving role in the management of advanced prostate cancer.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 3, p. 334, doi. 10.4103/1008-682X.122593
- By:
- Publication type:
- Article
Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer.
- Published in:
- Asian Journal of Andrology, 2012, v. 14, n. 4, p. 520, doi. 10.1038/aja.2012.45
- By:
- Publication type:
- Article
Combining active immunotherapy with immune checkpoint blockade for the treatment of advanced prostate cancer.
- Published in:
- Asian Journal of Andrology, 2012, v. 14, n. 4, p. 655, doi. 10.1038/aja.2012.61
- By:
- Publication type:
- Article
Use of androgen deprivation therapy in prostate cancer: indications and prevalence.
- Published in:
- Asian Journal of Andrology, 2012, v. 14, n. 2, p. 177, doi. 10.1038/aja.2011.103
- By:
- Publication type:
- Article
Abiraterone acetate for prostate cancer: a new era of hormonal therapies.
- Published in:
- Asian Journal of Andrology, 2011, v. 13, n. 5, p. 663, doi. 10.1038/aja.2011.92
- By:
- Publication type:
- Article
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 1052, doi. 10.1007/s10637-019-00731-5
- By:
- Publication type:
- Article
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 4, p. 225, doi. 10.1002/gcc.22824
- By:
- Publication type:
- Article
In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? Yes; We Must Beware of Drawing Conclusions From a Subset Analysis.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 10, p. 880
- By:
- Publication type:
- Article
Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 12, p. 2623, doi. 10.1007/s00345-018-2477-2
- By:
- Publication type:
- Article
Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2231475, doi. 10.1001/jamanetworkopen.2022.31475
- By:
- Publication type:
- Article
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.
- Published in:
- NPJ Genomic Medicine, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41525-024-00392-1
- By:
- Publication type:
- Article
Characterization of FOLH1 Expression in Renal Cell Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1855, doi. 10.3390/cancers16101855
- By:
- Publication type:
- Article
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1572, doi. 10.3390/cancers16081572
- By:
- Publication type:
- Article
AR Splicing Variants and Resistance to AR Targeting Agents.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2563, doi. 10.3390/cancers13112563
- By:
- Publication type:
- Article
AR Signaling in Human Malignancies: Prostate Cancer and Beyond.
- Published in:
- Cancers, 2018, v. 10, n. 1, p. 22, doi. 10.3390/cancers10010022
- By:
- Publication type:
- Article
Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer.
- Published in:
- Cancers, 2015, v. 7, n. 4, p. 1983, doi. 10.3390/cancers7040871
- By:
- Publication type:
- Article
New Approaches to Targeting the Androgen Receptor Pathway in Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 4, p. 228
- By:
- Publication type:
- Article
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection.
- Published in:
- Endocrinology, 2024, v. 165, n. 4, p. 1, doi. 10.1210/endocr/bqae022
- By:
- Publication type:
- Article
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00713-8
- By:
- Publication type:
- Article
Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7148
- By:
- Publication type:
- Article
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.
- Published in:
- Prostate Cancer (20903111), 2017, p. 1, doi. 10.1155/2017/8560827
- By:
- Publication type:
- Article
Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 8, p. 565, doi. 10.1177/1758834017719215
- By:
- Publication type:
- Article
Castration-resistant prostate cancer: latest evidence and therapeutic implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 4, p. 167, doi. 10.1177/1758834014529176
- By:
- Publication type:
- Article
Sequencing Treatment for Castration-Resistant Prostate Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 6, p. 807, doi. 10.4103/1008-682X.137680
- By:
- Publication type:
- Article
Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Liquid biopsy: Clues on prostate cancer drug resistance.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 312, p. 1, doi. 10.1126/scitranslmed.aad4008
- By:
- Publication type:
- Article
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 269, p. 1, doi. 10.1126/scitranslmed.3010563
- By:
- Publication type:
- Article
Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 4, p. 901, doi. 10.3390/v15040901
- By:
- Publication type:
- Article
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born.
- Published in:
- Therapeutic Advances in Urology, 2012, v. 4, n. 4, p. 167, doi. 10.1177/1756287212452196
- By:
- Publication type:
- Article
SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1417, doi. 10.2967/jnumed.123.265952
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate- Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Detection of Early Progression with 18F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article
Detection of Early Progression with <sup>18</sup>F‐DCFPyL PET/CT in Men with Metastatic Castration‐Resistant Prostate Cancer Receiving Bipolar Androgen Therapy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259226
- By:
- Publication type:
- Article